Reported Consolidated quarterly numbers for GlaxoSmithKline Pharmaceuticals are:Net Sales at Rs 648.59 crore in June 2020 down 17.69% from Rs. 787.97 crore in June 2019.
Quarterly Net Profit at Rs. 110.83 crore in June 2020 down 2.39% from Rs. 113.54 crore in June 2019.
EBITDA stands at Rs. 171.99 crore in June 2020 down 12.29% from Rs. 196.10 crore in June 2019.
GlaxoSmithKline EPS has decreased to Rs. 6.54 in June 2020 from Rs. 6.70 in June 2019.
GlaxoSmithKline shares closed at 1,464.30 on July 28, 2020 (NSE) and has given -13.67% returns over the last 6 months and 22.30% over the last 12 months.
| GlaxoSmithKline Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'20 | Mar'20 | Jun'19 | | Net Sales/Income from operations | 648.59 | 775.80 | 787.97 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 648.59 | 775.80 | 787.97 | | EXPENDITURE | | Consumption of Raw Materials | 106.72 | 98.33 | 169.04 | | Purchase of Traded Goods | 148.42 | 201.28 | 298.95 | | Increase/Decrease in Stocks | 2.19 | -20.15 | -137.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 151.92 | 171.58 | 142.81 | | Depreciation | 21.77 | 22.59 | 19.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 125.27 | 151.20 | 149.08 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 92.30 | 150.97 | 146.23 | | Other Income | 57.92 | 15.82 | 30.81 | | P/L Before Int., Excpt. Items & Tax | 150.22 | 166.79 | 177.04 | | Interest | 1.08 | 1.51 | 0.93 | | P/L Before Exceptional Items & Tax | 149.14 | 165.28 | 176.11 | | Exceptional Items | -- | 11.27 | -- | | P/L Before Tax | 149.14 | 176.55 | 176.11 | | Tax | 38.31 | 38.48 | 62.57 | | P/L After Tax from Ordinary Activities | 110.83 | 138.07 | 113.54 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 110.83 | 138.07 | 113.54 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 110.83 | 138.07 | 113.54 | | Equity Share Capital | 169.41 | 169.41 | 169.41 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 6.54 | 8.15 | 6.70 | | Diluted EPS | 6.54 | 8.15 | 6.70 | | EPS After Extra Ordinary | | Basic EPS | 6.54 | 8.15 | 6.70 | | Diluted EPS | 6.54 | 8.15 | 6.70 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
